𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors

✍ Scribed by Michael S. Gordon,David S. Mendelson,Mitchell Gross…


Book ID
126354443
Publisher
Springer US
Year
2012
Tongue
English
Weight
200 KB
Volume
31
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES